AdvanSix (ASIX) Q1 2026 earnings summary

Executive summary

• Achieved 7% year-over-year sales growth in Q1 2026 to $404 million, driven by Chemical Intermediates volume and Plant Nutrients pricing, despite winter storm impacts and subdued industrial demand.

• Net loss of $15.5 million and adjusted EPS of $(0.50), reflecting higher raw material and utility costs, absence of prior year insurance proceeds, and winter storm impacts.

• Adjusted EBITDA dropped to $4.8 million (1.2% margin) from $51.6 million (13.7% margin) year-over-year.

• Announced plans to expand the integrated ammonia platform for DEF production at the Hopewell, VA site, targeting operational startup in 2029, with FEED work underway and investment decision targeted for H1 2027.

• Appointed Patrick Day as SVP and CFO, effective April 27, 2026.

Financial highlights

• Q1 2026 sales reached $404.2 million, up 7% year-over-year, with 6% volume growth and 1% favorable price.

• Adjusted EBITDA was $4.8 million, down $46.9 million year-over-year, mainly due to absence of $26 million insurance proceeds and higher input costs.

• Net loss of $15.5 million in Q1 2026 compared to net income of $23.3 million in Q1 2025.

• Free cash flow was seasonally negative at $(51.3) million, reflecting CapEx timing and lack of insurance proceeds.

• Capital expenditures increased to $35.9 million from $34.1 million year-over-year.

Outlook and guidance

• Anticipates significant sequential earnings and cash flow improvement in Q2 2026.

• Full-year 2026 CapEx expected in the $75–$95 million range, down from ~$116 million in 2025, with nearly 20% allocated to high-return growth investments.

• Debt leverage ratios expected near the low end of the 1x–2.5x target range by year-end.

• Expects to recoup raw material cost shortfalls in Q2, especially in plant nutrients.

• Expects cash flow benefit from 45Q carbon capture tax credits and 100% bonus depreciation, with $18 million expected in the second half of 2026, pending IRS approval.